semaglutide or tirzepatide for weight loss and treatment leads to in type 1 diabetes Semaglutide vs. Tirzepatide for Weight
Description
Detailed results from SURMOUNT-4 have shown Zepbound (tirzepatide) injection achieved superior mean percent change in body weight compared to placebo in adults with obesity or overweight with weight-related comorbidities, excluding type 2 diabetes

New clinical publication from Prime Therapeutics explores the latest insights for GLP-1s, including trends in spend, drugs in the pipeline, management strategies and more

Corticosteroids can increase appetite and water retention, potentially offsetting GLP-1 medication benefits

At Skinjectables, were all about giving you resultswithout the guesswork

Designed for adults this formula is an ideal choice for those seeking targeted gut-centric wellness

[email protected] OPEN ACCESS PUBLISHED: 30 April 2026 CITATION Joshi, A., and Li, D., 2026
